基金经理：田希蒙
| 单位净值:1.0807 | 净值增长率:1.53% | 累计净值:1.0807 | 截止日期:2026/6/10 | ||
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:1.25亿元 | 风险等级:高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
富国恒生港股通创新药及医疗保健ETF发起式联接A(020110)历史净值 |
||||
|---|---|---|---|---|
| 日期 | 单位净值(元) | 累计净值(元) | 净值增长率 | |
| 2026/6/10 | 1.0807 | 1.0807 | 1.531% | |
| 2026/6/9 | 1.0644 | 1.0644 | -1.078% | |
| 2026/6/8 | 1.076 | 1.076 | -2.35% | |
| 2026/6/5 | 1.1019 | 1.1019 | -1.44% | |
| 2026/6/4 | 1.118 | 1.118 | -1.044% | |
| 2026/6/3 | 1.1298 | 1.1298 | -2.283% | |
| 2026/6/2 | 1.1562 | 1.1562 | -2.29% | |
| 2026/6/1 | 1.1833 | 1.1833 | -2.053% | |
| 2026/5/29 | 1.2081 | 1.2081 | 4.165% | |
| 2026/5/28 | 1.1598 | 1.1598 | -4.038% | |
| 2026/5/27 | 1.2086 | 1.2086 | -0.641% | |
| 2026/5/26 | 1.2164 | 1.2164 | -1.594% | |
| 2026/5/25 | 1.2361 | 1.2361 | -0.065% | |
| 2026/5/22 | 1.2369 | 1.2369 | 0.097% | |
| 2026/5/21 | 1.2357 | 1.2357 | 1.428% | |
| 2026/5/20 | 1.2183 | 1.2183 | 0.247% | |
| 2026/5/19 | 1.2153 | 1.2153 | -0.719% | |
| 2026/5/18 | 1.2241 | 1.2241 | -2.61% | |
| 2026/5/15 | 1.2569 | 1.2569 | -2.589% | |
| 2026/5/14 | 1.2903 | 1.2903 | -1.549% | |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。